Oestrogen receptor function at classical and alternative response elements

Novartis Foundation Symposium

Volumn 230, Issue , 2000, Pages 20-32

  Kushner, Peter J ^b   Agard, David ^b   Feng, Wei Jun ^b   Lopez, Gabriela ^b   Schiau, Andrew ^b   Uht, Rosalie ^b   Webb, Paul ^b   Greene, Geoffrey ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; LIGAND; TAMOXIFEN; TRANSCRIPTION FACTOR AP 1;

ANIMAL; DNA RESPONSIVE ELEMENT; METABOLISM; PHYSIOLOGY; PROMOTER REGION; PROTEIN TERTIARY STRUCTURE; REVIEW;

ANIMALS; ESTROGEN ANTAGONISTS; LIGANDS; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TAMOXIFEN; TRANSCRIPTION FACTOR AP-1;

EID: 0033642427     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (22)

1. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
2. Brzozowski AM, Pike AC, Dauter Z et al 1997 Insights into the molecular basis of agonism and antagonism in the oestrogen receptor as revealed by complexes with 17β-oestradiol and raloxifene. Nature 389:753-758
3. Chen H, Lin RJ, Schiltz RL et al 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580
4. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033 (erratum: 1992 EMBO J 11:2366)
5. Darimont BD, Wagner RL, Apriletti JW et al 1998 Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12:3343-3356
6. Ding XF, Anderson CM, Ma H et al 1998 Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol 12:302-313
7. Feng W, Ribero RC, Wagner RL et al 1998 Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749
8. Heery DM, Kalkhoven E, Hoare S, Parker MG 1997 A signature motif in transcriptional coactivators mediates binding to nuclear receptors. Nature 387:733-736
9. Henttu PM, Kalkhoven E, Parker MG 1997 AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 17:1832-1839
10. Le Douarin B, Nielsen AL, Gamier JM et al 1996 A possible involvement of TIF1α and TIF1β in the epigenetic control of transcription by nuclear receptors. EMBO J 15:6701-6715
11. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959
12. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
13. Parker MG 1998 Transcriptional activation by oestrogen receptors. Biochem Soc Symp 63:45-50
14. Shiau AK, Barstad D, Loria PM et al 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
15. Spencer TE, Jenster G, Burcin MM et al 1997 Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198
16. Tremblay A, Tremblay GB, Labrie F, Giguère V 1999 Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol Cell 3:513-519
17. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H 1998 The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 17:507-519
18. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/ AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
19. Webb P, Nguyen P, Shinsako J et al 1998 Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol 12:1605-1618
20. Webb P, Nguyen P, Valentine C et al 1999 The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13:1672-1685
21. Xu L, Glass CK, Rosenfeld MG 1999 Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9:140-147
22. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y 1996 A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319-324